Vera Therapeutics Inc
VERA
Company Profile
Business description
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Contact
8000 Marina Boulevard
Suite 120
BrisbaneCA94005
USAT: +1 650 770-0077
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
112
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,421.70 | 21.90 | 0.26% |
| CAC 40 | 7,690.68 | 63.84 | 0.84% |
| DAX 40 | 23,312.10 | 196.14 | 0.85% |
| Dow JONES (US) | 41,113.97 | 284.97 | 0.70% |
| FTSE 100 | 8,554.65 | 4.68 | -0.05% |
| HKSE | 22,775.92 | 84.04 | 0.37% |
| NASDAQ | 17,738.16 | 48.50 | 0.27% |
| Nikkei 225 | 36,928.63 | 148.97 | 0.41% |
| NZX 50 Index | 12,467.03 | 29.86 | -0.24% |
| S&P 500 | 5,631.28 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,191.70 | 13.40 | 0.16% |
| SSE Composite Index | 3,352.00 | 9.33 | 0.28% |